Jin Cui - JoVE Visualize

Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Policies

Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Policies

Filters

Jin Cui

Showing results (501-510 of 503) with videos related to

Pageof 51

Sort By:

You have reached the last page of results.This site can display upto 503 results.

Communications Medicine|January 18, 2025

FORCE platform overcomes barriers of oligonucleotide delivery to muscle and corrects myotonic dystrophy features in preclinical modelsTimothy Weeden, Tyler Picariello, Brendan Quinn, et al.

Signal Transduction and Targeted Therapy|December 7, 2021

Azvudine is a thymus-homing anti-SARS-CoV-2 drug effective in treating COVID-19 patientsJin-Lan Zhang, Yu-Huan Li, Lu-Lu Wang, et al.

Nature Genetics|March 8, 2011

Genome-wide association identifies a susceptibility locus for coronary artery disease in the Chinese Han populationFan Wang, Cheng-Qi Xu, Qing He, et al.

Pageof 51

Search research articles

Showing results (501-510 of 503) with videos related to

Sort By:

Pageof 51

You have reached the last page of results.This site can display upto 503 results.

Communications Medicine|January 18, 2025

FORCE platform overcomes barriers of oligonucleotide delivery to muscle and corrects myotonic dystrophy features in preclinical modelsTimothy Weeden, Tyler Picariello, Brendan Quinn, et al.

Signal Transduction and Targeted Therapy|December 7, 2021

Azvudine is a thymus-homing anti-SARS-CoV-2 drug effective in treating COVID-19 patientsJin-Lan Zhang, Yu-Huan Li, Lu-Lu Wang, et al.

Nature Genetics|March 8, 2011

Genome-wide association identifies a susceptibility locus for coronary artery disease in the Chinese Han populationFan Wang, Cheng-Qi Xu, Qing He, et al.

Pageof 51